Literature DB >> 21471092

Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways.

Per Brandtzaeg1.   

Abstract

Nasopharynx-associated lymphoid tissue (NALT), constituting Waldeyer's ring in humans, is a unique inductive site for B-cell responses and plasma cell generation. This makes the nasal route of vaccine administration interesting for induction of mucosal and systemic antibodies. The unpaired nasopharyngeal tonsil (adenoids) and the paired palatine tonsils are prominent NALT structures, functionally similar to the paired rodent NALT structures located dorsal to the cartilaginous soft palate. Human NALT is more strategically located, however, because its elements are exposed to both airborne and alimentary antigens and have antigen-retaining crypts. It also shows similarities with lymph nodes and participates both in systemic- and secretory-type mucosal immunity. Primary follicles occur at 16 weeks of gestation, which is similar to Peyer's patches but different from rodent NALT whose organogenesis begins at birth. The formation of germinal centers reflecting B-cell activation does not take place until shortly after birth, and terminal differentiation of plasma cell can be seen about 2 weeks postnatally. Germinal centers arise in T cell-dependent B-cell responses and are associated with somatic hypermutation of Ig V-region genes. Downstream switching to various Ig isotypes also takes place, with or without concurrent expression of the J-chain gene. The J chain is a crucial part of dimeric IgA and pentameric IgM, making these Ig polymers able to interact with the epithelial polymeric Ig receptor. This interaction is central in the formation of secretory IgA and secretory IgM. Accumulating evidence suggests a major role for NALT in antibody immunity of the respiratory tract and associated glands.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21471092     DOI: 10.1164/rccm.201011-1783OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  54 in total

1.  Nasal immunity is an ancient arm of the mucosal immune system of vertebrates.

Authors:  Luca Tacchi; Rami Musharrafieh; Erin T Larragoite; Kyle Crossey; Erik B Erhardt; Samuel A M Martin; Scott E LaPatra; Irene Salinas
Journal:  Nat Commun       Date:  2014-10-22       Impact factor: 14.919

2.  Current understanding of nasal morphology and physiology as a drug delivery target.

Authors:  Julie D Suman
Journal:  Drug Deliv Transl Res       Date:  2013-02       Impact factor: 4.617

Review 3.  Gas-filled microbubbles: Novel mucosal antigen-delivery system for induction of anti-pathogen's immune responses in the gut.

Authors:  Blaise Corthésy; Gilles Bioley
Journal:  Gut Microbes       Date:  2017-05-25

Review 4.  Recent progress in mucosal vaccine development: potential and limitations.

Authors:  Nils Lycke
Journal:  Nat Rev Immunol       Date:  2012-07-25       Impact factor: 53.106

Review 5.  B-lymphocyte lineage cells and the respiratory system.

Authors:  Atsushi Kato; Kathryn E Hulse; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

6.  B cell response to herpesvirus infection of the olfactory neuroepithelium.

Authors:  Cindy S E Tan; Philip G Stevenson
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

7.  Adenoidal follicular T helper cells provide stronger B-cell help than those from tonsils.

Authors:  Matthew C Morris; Kevin Kozara; Frank Salamone; Margo Benoit; Michael E Pichichero
Journal:  Laryngoscope       Date:  2015-10-29       Impact factor: 3.325

Review 8.  Murine models for mucosal tolerance in allergy.

Authors:  Ursula Smole; Irma Schabussova; Winfried F Pickl; Ursula Wiedermann
Journal:  Semin Immunol       Date:  2017-08-12       Impact factor: 11.130

9.  Transcutaneous immunization with a nontypeable Haemophilus influenzae dual adhesin-directed immunogen induces durable and boostable immunity.

Authors:  Laura A Novotny; Lauren O Bakaletz
Journal:  Vaccine       Date:  2020-01-27       Impact factor: 3.641

10.  Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome.

Authors:  Zhiwei Liu; Anna E Coghill; Ruth M Pfeiffer; Carla Proietti; Wan-Lun Hsu; Yin-Chu Chien; Lea Lekieffre; Lutz Krause; Kelly J Yu; Pei-Jen Lou; Cheng-Ping Wang; Jason Mulvenna; Jaap M Middeldorp; Jeff Bethony; Chien-Jen Chen; Denise L Doolan; Allan Hildesheim
Journal:  J Infect Dis       Date:  2018-05-25       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.